The movement of lymphocytes from the blood into secondary lymphoid organs and back to the blood again is known as lymphocyte recirculation. This process is an important component of immune surveillance, as it facilitates the exposure of the body's repertoire of lymphocyte specificities to sequestered and processed antigens in the lymphoid organs. In certain diseases the migration of lymphocytes into inappropriate compartments (i.e, joint synovia during rheumatoid arthritis) leads to tissue damage. The overall objective of our research is to understand the biochemical mechanisms involved in the attachment of blood- borne lymphocytes to specialized high endothelial venules (HEV) found in secondary lymphoid organs. This highly specific cell-cell recognition event, which is dependent on both lymphocyte type and the anatomic site of the HEV, initiates the extravasation of normal lymphocytes from the blood into the parenchyma of lymphoid organs and may also determine the dissemination sites of lymphoid malignancies. Our previous work has established that lymphocytes express a cell surface carbohydrate-binding receptor (CBR) that participate in the attachment of lymphocyte to HEV in peripheral lymph nodes (i.e., """"""""lymphocyte homing receptor""""""""). Also we established that the lymphocyte attachment sites on PN HEV require sialic acid for their activity. The major objectives of our proposed research are: 1) to determine the relationship between the CBR and the MEL-14 antigen, a 80 kDa glycoprotein previously implicated in lymphocyte homing; 2) to determine the relationship between a soluble lymph factor with specific HEV- binding activity and the CBR; 3) to identify the linkage of sialic acid required for the activity of PN HEV attachment sites; 4) to identify the actual attachment sites for lymphocytes on PN HEV and PP HEV; and 5) to identify the homing receptor that mediates attachment of lymphocytes to HEV in Peyer's patches, a gutassociated lymphoid organ.

Agency
National Institute of Health (NIH)
Institute
National Institute of General Medical Sciences (NIGMS)
Type
Research Project (R01)
Project #
5R01GM023547-12
Application #
3271717
Study Section
Cellular Biology and Physiology Subcommittee 1 (CBY)
Project Start
1977-02-01
Project End
1992-07-31
Budget Start
1988-08-01
Budget End
1989-07-31
Support Year
12
Fiscal Year
1988
Total Cost
Indirect Cost
Name
University of California San Francisco
Department
Type
Schools of Medicine
DUNS #
073133571
City
San Francisco
State
CA
Country
United States
Zip Code
94143
Patnode, Michael L; Bando, Jennifer K; Krummel, Matthew F et al. (2014) Leukotriene B4 amplifies eosinophil accumulation in response to nematodes. J Exp Med 211:1281-8
Patnode, Michael L; Cheng, Chu-Wen; Chou, Chi-Chi et al. (2013) Galactose 6-O-sulfotransferases are not required for the generation of Siglec-F ligands in leukocytes or lung tissue. J Biol Chem 288:26533-45
Patnode, Michael L; Yu, Shin-Yi; Cheng, Chu-Wen et al. (2013) KSGal6ST generates galactose-6-O-sulfate in high endothelial venules but does not contribute to L-selectin-dependent lymphocyte homing. Glycobiology 23:381-94
Zhang, Yafeng; Chen, Yi-Chun Maria; Krummel, Matthew F et al. (2012) Autotaxin through lysophosphatidic acid stimulates polarization, motility, and transendothelial migration of naive T cells. J Immunol 189:3914-24
Arata-Kawai, Hanayo; Singer, Mark S; Bistrup, Annette et al. (2011) Functional contributions of N- and O-glycans to L-selectin ligands in murine and human lymphoid organs. Am J Pathol 178:423-33
Kerr, Sheena C; Fieger, Claudia B; Snapp, Karen R et al. (2008) Endoglycan, a member of the CD34 family of sialomucins, is a ligand for the vascular selectins. J Immunol 181:1480-90
Kanda, Hidenobu; Newton, Rebecca; Klein, Russell et al. (2008) Autotaxin, an ectoenzyme that produces lysophosphatidic acid, promotes the entry of lymphocytes into secondary lymphoid organs. Nat Immunol 9:415-23
Veerman, Krystle M; Williams, Michael J; Uchimura, Kenji et al. (2007) Interaction of the selectin ligand PSGL-1 with chemokines CCL21 and CCL19 facilitates efficient homing of T cells to secondary lymphoid organs. Nat Immunol 8:532-9
Uchimura, Kenji; Rosen, Steven D (2006) Sulfated L-selectin ligands as a therapeutic target in chronic inflammation. Trends Immunol 27:559-65
Bowman, K G; Hemmerich, S; Bhakta, S et al. (1998) Identification of an N-acetylglucosamine-6-0-sulfotransferase activity specific to lymphoid tissue: an enzyme with a possible role in lymphocyte homing. Chem Biol 5:447-60

Showing the most recent 10 out of 35 publications